Roshni Kulkarni

Physician
Department of Pediatrics and Human Development, Michigan State University, East Lansing, Michigan, USA

Presentation(s):

• LB 01.4 - Efficacy, Safety, and Pharmacokinetics of Once-Weekly Efanesoctocog Alfa (BIVV001) Prophylaxis in Previously Treated Patients With Severe Hemophilia A: Results From the Phase 3 XTEND-1 Study

  Sunday, July 10, 2022
  3:30 PM – 3:45 PM

• OC 47.4 - A Post Hoc Analysis of Individuals With Severe Hemophilia A and Inhibitors From the PUPs A-LONG Study

  Monday, July 11, 2022
  3:30 PM – 3:45 PM